ZA847440B - Insulin derivatives modified in the b30 position,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus - Google Patents

Insulin derivatives modified in the b30 position,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus

Info

Publication number
ZA847440B
ZA847440B ZA847440A ZA847440A ZA847440B ZA 847440 B ZA847440 B ZA 847440B ZA 847440 A ZA847440 A ZA 847440A ZA 847440 A ZA847440 A ZA 847440A ZA 847440 B ZA847440 B ZA 847440B
Authority
ZA
South Africa
Prior art keywords
des
group
human insulin
phe
treatment
Prior art date
Application number
ZA847440A
Inventor
Ulrich Grau
Rolf Geiger
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA847440B publication Critical patent/ZA847440B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE A medicament having a delayed action for the treatment of diabetes mellitus, comprising at least one insulin derivative of the formula I see diagramm : EP0137361,P16,F1 in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH2 and des-B30 human insulin Phe**B30 -NH2 and a pharmaceutically acceptable carrier. 1. Claims for the Contracting State : AT A process for the preparation of a medicament having a delayed action for the treatment of diabetes mellitus, which comprises bringing into a suitable dosage form at least one insulin derivative of the formula I see diagramm : EP0137361,P17,F1 in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH, and des-B30 human insulin Phe**B30 -NH2 Phe**B30 -NH2 and a pharmaceutically acceptable carrier.
ZA847440A 1983-09-23 1984-09-21 Insulin derivatives modified in the b30 position,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus ZA847440B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833334407 DE3334407A1 (en) 1983-09-23 1983-09-23 INSULINE DERIVATIVES MODIFIED IN POSITION B 30, METHOD FOR THE PRODUCTION AND USE THEREOF AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF THE DIABETES MELLITUS

Publications (1)

Publication Number Publication Date
ZA847440B true ZA847440B (en) 1985-05-29

Family

ID=6209839

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA847440A ZA847440B (en) 1983-09-23 1984-09-21 Insulin derivatives modified in the b30 position,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus

Country Status (18)

Country Link
EP (1) EP0137361B1 (en)
JP (1) JPS6094999A (en)
KR (1) KR850002287A (en)
AT (1) ATE52791T1 (en)
AU (1) AU573624B2 (en)
CA (1) CA1247545A (en)
DE (2) DE3334407A1 (en)
DK (1) DK172632B1 (en)
ES (1) ES8505647A1 (en)
FI (1) FI843695L (en)
GR (1) GR80441B (en)
HU (1) HUT36843A (en)
IE (1) IE57669B1 (en)
IL (1) IL73021A (en)
NO (1) NO843799L (en)
NZ (1) NZ209620A (en)
PT (1) PT79249A (en)
ZA (1) ZA847440B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326472A1 (en) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt NEW INSULIN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AND PHARMACEUTICAL AGENTS FOR TREATING THE DIABETES MELLITUS
DE3327928A1 (en) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING INSULIN DERIVATIVES
DE3333640A1 (en) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt METHOD FOR THE PRODUCTION OF INSULIN DERIVATIVES, THE B-CHAIN C-TERMINAL EXTENDED, NEW BASICALLY MODIFIED INSULIN DERIVATIVES, THE MEANS CONTAINING THEM AND THEIR USE
DE3827533A1 (en) * 1988-08-13 1990-02-15 Hoechst Ag PHARMACEUTICAL PREPARATION FOR TREATING THE DIABETES MELLITUS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2069502A (en) * 1936-04-21 1937-02-02 American Floor Surfacing Mach Sanderplane
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE2433883C2 (en) * 1973-07-20 1986-03-27 Research Corp., New York, N.Y. Use of physiologically active polypeptides
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
JPS5767548A (en) * 1980-10-14 1982-04-24 Shionogi & Co Ltd Insulin analog and its preparation
DE3101382A1 (en) * 1981-01-17 1982-09-02 Hoechst Ag, 6000 Frankfurt "METHOD FOR PRODUCING HUMANISULIN OR ITS DERIVATIVES FROM PIG INSULIN OR ITS DERIVATIVES"
DE3333640A1 (en) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt METHOD FOR THE PRODUCTION OF INSULIN DERIVATIVES, THE B-CHAIN C-TERMINAL EXTENDED, NEW BASICALLY MODIFIED INSULIN DERIVATIVES, THE MEANS CONTAINING THEM AND THEIR USE

Also Published As

Publication number Publication date
IE842415L (en) 1985-03-23
JPS6094999A (en) 1985-05-28
DK453084A (en) 1985-03-24
KR850002287A (en) 1985-05-10
AU3341984A (en) 1985-03-28
AU573624B2 (en) 1988-06-16
DE3482265D1 (en) 1990-06-21
HUT36843A (en) 1985-10-28
FI843695A0 (en) 1984-09-20
ES536115A0 (en) 1985-06-01
PT79249A (en) 1984-10-01
DE3334407A1 (en) 1985-04-04
NO843799L (en) 1985-03-25
IL73021A0 (en) 1984-12-31
EP0137361A2 (en) 1985-04-17
FI843695L (en) 1985-03-24
ES8505647A1 (en) 1985-06-01
IE57669B1 (en) 1993-02-24
GR80441B (en) 1985-01-21
EP0137361A3 (en) 1987-05-06
CA1247545A (en) 1988-12-28
ATE52791T1 (en) 1990-06-15
IL73021A (en) 1989-09-10
DK172632B1 (en) 1999-03-22
DK453084D0 (en) 1984-09-21
EP0137361B1 (en) 1990-05-16
NZ209620A (en) 1988-03-30

Similar Documents

Publication Publication Date Title
DE3466227D1 (en) Insulin derivatives, processes for their preparation, their use and pharmaceutical compositions for the treatment of diabetes mellitus
ZA876731B (en) Therapeutic agents
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
DE3468323D1 (en) Pharmaceutical formulation for the treatment of diabetes mellitus
HK129393A (en) Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus
IL77186A0 (en) Pharmaceutical insulin composition
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
ZA847440B (en) Insulin derivatives modified in the b30 position,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
WO1990003172A3 (en) Bile acids for treatment of viral infections
CA2145501A1 (en) Method for treatment or prevention of obesity
JPS6466138A (en) (6)-gingerol derivative
EP0323604A3 (en) A venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound
Mitsuya et al. Antiviral compositions and methods.
EP0253777A3 (en) Use of l-carnitine in the treatment of toxic effects induced by the inhalation of halotane and other halogen-containing general anesthetics
JPS55136054A (en) Throwaway band for preventing boat bug doubling as medical treatment